Springbok Capital Management »

Neubase Therapeutics shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Neubase Therapeutics (NBSE) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Neubase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neubase Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neubase Therapeutics by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.0k 16k 0.45
2023-09-30 $14k 16k 0.87
2023-06-30 $29k 16k 1.87